Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.2M Hold
2,000,000
4.75% 4
2026
Q1
$56.2M Buy
2,000,000
+480,200
+32% +$12.8M 5.57% 4
2025
Q4
$37.8M Hold
1,519,800
3.61% 4
2025
Q3
$38.7M Buy
1,519,800
+500,000
+49% +$12.3M 3.65% 4
2025
Q2
$24.7M Hold
1,019,800
2.43% 4
2025
Q1
$25.8M Hold
1,019,800
2.69% 5
2024
Q4
$27.1M Buy
1,019,800
+19,800
+2% +$537K 2.97% 4
2024
Q3
$28.9M Buy
1,000,000
+500,000
+100% +$14.6M 3.12% 6
2024
Q2
$14M Hold
500,000
1.75% 6
2024
Q1
$13.9M Buy
500,000
+300,000
+150% +$8.32M 1.75% 6
2023
Q4
$5.76M Sell
200,000
-100,000
-33% -$3.02M 0.8% 7
2023
Q3
$9.95M Hold
300,000
1.39% 7
2023
Q2
$11M Hold
300,000
1.48% 7
2023
Q1
$12.2M Hold
300,000
1.74% 7
2022
Q4
$15.4M Hold
300,000
2.18% 7
2022
Q3
$13.1M Hold
300,000
2.06% 7
2022
Q2
$15.7M Hold
300,000
2.26% 7
2022
Q1
$15.5M Hold
300,000
2.01% 7
2021
Q4
$17.7M Hold
300,000
2.38% 7
2021
Q3
$12.9M Buy
+300,000
New +$13.3M 1.91% 8

Other funds holding PFE

Allen Holding's PFE Position: Q2 2026 in Review

Allen Holding held its Pfizer (PFE) position steady in Q2 2026 at 2,000,000 shares worth $48.2M. The position accounts for 4.75% of the portfolio, ranked #4.

Allen Holding first reported a position in PFE in Q3 2021 and has held it in 20 quarters since. The position peaked at $56.2M in Q1 2026. 1,599 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Allen Holding held 2,000,000 shares of Pfizer worth $48.2M as of Q2 2026.
  • Allen Holding left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 4.75% of Allen Holding's portfolio in Q2 2026, its #4 holding.
  • Allen Holding first reported a position in Pfizer in Q3 2021 and has held it in 20 quarters since.
  • Allen Holding's Pfizer position peaked at $56.2M in Q1 2026.
  • 1,599 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Allen Holding's 13F filing for Q2 2026, filed 5 Aug 2026.